Differentiation of the MRNA Transcripts Originating from the Alpha 1- and Alpha 2-globin Loci in Normals and Alpha-thalassemics
Overview
Authors
Affiliations
The alpha-globin polypeptide is encoded by two adjacent genes, alpha 1 and alpha 2. In the normal diploid state (alpha alpha/alpha alpha) all four alpha-globin genes are expressed. Loss or dysfunction of one or more of these genes leads to deficient alpha-globin production and results in alpha-thalassemia. We present a technique to differentially assess the steady-state levels of the alpha 1- and alpha-2-globin messenger RNA (mRNA) transcripts and thus delineate the relative level of expression of the two alpha-globin loci in a variety of alpha-thalassemia states. Only alpha 1 mRNA was produced in the alpha-thalassemia-2 haplotype (-alpha) (one of the two alpha-globin genes deleted from chromosome 16). This confirms previous gene mapping data which demonstrate deletion of the alpha 2 gene. The triple alpha-globin gene haplotype (alpha alpha alpha) is the reciprocal of the alpha-thalassemia-2 haplotype and thus contains an extra alpha 2-globin gene. RNA from this haplotype contained a greater than normal level of alpha 2-relative to alpha 1-globin mRNA. This data implies that the extra alpha 2 gene in the triple alpha-globin haplotype is functional. We detected a relative instability of the alpha 2-globin mRNA encoding the alpha-globin structural mutant Constant Spring. This instability may contribute to the low level of expression of the alpha-Constant Spring protein. In a Chinese patient with nondeletion hemoglobin-H disease (- -/alpha alpha T) (both alpha-globin genes are present but not fully functional) a normal ratio was maintained between the levels of alpha 1- and alpha 2-globin mRNA, implying that mRNA production from both alpha-globin genes is suppressed in a balanced manner. These observations extended previous findings concerning the structural rearrangements in the deletion types of alpha-thalassemia and the pathophysiology of two nondeletion variants.
Lachover-Roth I, Peretz S, Zoabi H, Harel E, Livshits L, Filon D Int J Mol Sci. 2024; 25(12).
PMID: 38928152 PMC: 11203927. DOI: 10.3390/ijms25126446.
Genetic Analysis of Alpha-Thalassemia Mutations in Thi-Gar Province, Iraq.
Odah Al-Musawi A, Jumaah Alhussna A, Hussein Jalood H Arch Razi Inst. 2023; 77(3):976-980.
PMID: 36618297 PMC: 9759236. DOI: 10.22092/ARI.2022.357209.1997.
A Small Key for a Heavy Door: Genetic Therapies for the Treatment of Hemoglobinopathies.
Zittersteijn H, Harteveld C, Klaver-Flores S, Lankester A, Hoeben R, Staal F Front Genome Ed. 2021; 2:617780.
PMID: 34713239 PMC: 8525365. DOI: 10.3389/fgeed.2020.617780.
Hockham C, Ekwattanakit S, Bhatt S, Penman B, Gupta S, Viprakasit V Elife. 2019; 8.
PMID: 31120421 PMC: 6533055. DOI: 10.7554/eLife.40580.
Translation readthrough mitigation.
Arribere J, Cenik E, Jain N, Hess G, Lee C, Bassik M Nature. 2016; 534(7609):719-23.
PMID: 27281202 PMC: 5054982. DOI: 10.1038/nature18308.